Practices should be evaluated for cytotoxic chemotherapy extravasation
the ONA take:
The influence of patient experience in health care is driving a review of practices to ensure it plays a part in developing clinical practice guidelines.
This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation and determine if the patient experience is taken into account.
A literature search identified all studies on strategies aimed at preventing surgical debridement and all studies evaluating the patient’s perspective on extravasation management published from the 1960s to July 2014.
The researchers found no conclusive evidence that one clinical strategy is more effective than another, and no studies evaluated management strategies from the patient perspective.
The researchers suggest further outcomes-based studies are needed for extravasation management guidelines and how treatment impacts the patient.
In addition, they conclude that research into the patient experience of extravasation management needs to be addressed.
This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|